Pneumococcal serotype evolution in Western Europe - Wikidata - awgldk - TriplyDB

Pneumococcal serotype evolution in Western Europe

Pneumococcal serotype evolution in Western Europe

http://www.wikidata.org/entity/Q26782963

about

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world.Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.Serotype Distribution and Antimicrobial Susceptibilities of Invasive Streptococcus pneumoniae Isolates from Adults in Korea from 1997 to 2012 Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution.Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey.Strategies to develop vaccines of pediatric interest.Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany.Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children.Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.ASC and NLRP3 impair host defense during lethal pneumonia caused by serotype 3 Streptococcus pneumoniae in mice.Comprehensive vaccine design for commensal disease progression.Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly.

P2860

Q31157042-4C1FADA3-B9AD-4B65-9019-BAE00FF4345A Q36229752-7EC904DB-4193-4C2F-806C-E42EA359BDD5 Q36809649-DD495BD2-9E6B-4462-A532-F0E61CAC221E Q37554742-AB3C386C-467B-4C35-9113-B8A903C4CAAE Q38748755-7E07A57C-8CCC-4DEB-B06B-ACDEBDC780D8 Q38819027-F4915103-68CA-407F-B131-52D75E1B8757 Q39976528-E02764B9-19D0-47E2-9A5C-494C64AE0031 Q40401092-1FDDE698-572F-4673-AD62-A71393488E44 Q41383702-FF5AA11A-C3AE-482C-929C-2A511927EFDB Q41991833-DF33CB79-197A-4B60-9944-3E99FC2CEF4B Q47094231-0034B898-41D6-4665-BDE8-AE9261A305C7 Q55267236-CF9865C6-0535-40FF-86E0-27D1D7BA3A5A

P2860

Pneumococcal serotype evolution in Western Europe

http://www.wikidata.org/entity/Q26782963

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Pneumococcal serotype evolution in Western Europe

@ast

Pneumococcal serotype evolution in Western Europe

@en

Pneumococcal serotype evolution in Western Europe

@nl

type

label

Pneumococcal serotype evolution in Western Europe

@ast

Pneumococcal serotype evolution in Western Europe

@en

Pneumococcal serotype evolution in Western Europe

@nl

prefLabel

Pneumococcal serotype evolution in Western Europe

@ast

Pneumococcal serotype evolution in Western Europe

@en

Pneumococcal serotype evolution in Western Europe

@nl

P1433

Q26782963-EC628C99-E6FA-43D9-89BF-75EBBA6FF127

P1476

Q26782963-A3EE772D-CFC4-4185-BD10-30F79369857C

P2093

Q26782963-33678536-C592-4246-987B-02E3F6F152B5

Q26782963-5E5DFD97-29E3-4F34-A1CB-29F76C66FE59

Q26782963-6D5D4889-0B65-4961-8413-C988BEB1681F

P275

Q26782963-1BAF4521-BA53-4DA3-A7D9-3E36B927EC00

P2860

Q26782963-07FD05DE-69C9-4CB8-B2EB-E8DAD3D7FA98

Q26782963-08E37CBE-CFE9-466E-80B8-E1EEB4A30724

Q26782963-0D27CF7E-B33B-4036-9287-96B2980DFF2A

Q26782963-0EFA9368-BCB9-4B83-997A-8C778C348B45

Q26782963-1C111B12-C220-4043-930A-F734ED4375E4

Q26782963-1EFE1208-508E-45AE-ACB3-CF57E6BCE2D3

Q26782963-1F3142C9-CD4F-47FD-B8BB-CF80DAE53A48

Q26782963-1FC013F4-EA79-44A8-89B7-A41EEC9F0E5A

Q26782963-27D511EC-7BA2-429A-BD5C-F9E546AC2EC9

Q26782963-2CE32561-0217-4B74-B49E-F950AE0E5EED

P2888

Q26782963-3362C4DC-FCA2-4CDA-B870-0EBB0518E22F

P304

Q26782963-44EFBE11-365A-4C3A-80BA-3F3E65BF970C

P31

Q26782963-26071C0A-6293-4F6F-9992-3688689B04A4

Q26782963-BA2A154C-E4F8-43B4-9BAD-CCD94F663D36

P3181

Q26782963-52FA95F6-4B13-4682-B728-C6082796A96D

P356

Q26782963-D564F1C4-7D09-4031-8A79-A4429428E196

P407

Q26782963-6A7E8785-C9E3-4B62-A79C-E69CBBBE7213

P433

Q26782963-5FA5B1C5-FE10-4FDE-B314-02B61510C537

P478

Q26782963-0A45CA08-9544-4084-A50C-C9A3B1658E7D

P577

Q26782963-BA41FC59-66F6-42E1-9A0A-432405F53F3B

P698

Q26782963-DC2D92AC-984F-4489-A7F2-12194D6B0367

P921

Q26782963-AD3AC5B2-D7C2-44A2-B510-A1973778B38A

P932

Q26782963-C12FBBEC-6F01-4732-98E3-51DE1A68605C

P3181

P356

S12879-015-1147-X

P1433

BMC Infectious Diseases

P1476

Pneumococcal serotype evolution in Western Europe

@en

P2093

Dina Christopoulou

http://www.w3.org/2001/XMLSchema#string

Heinz-Josef Schmitt

http://www.w3.org/2001/XMLSchema#string

Myint Tin Tin Htar

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Invasive pneumococcal isolates from Danish infants (0 - 90 Days) during the years 1943 to 2013

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark

The majority of adult pneumococcal invasive infections in Portugal are still potentially vaccine preventable in spite of significant declines of serotypes 1 and 5.

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.

Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany

Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012.

Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.

The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.

P2888

s12879-015-1147-x

P304

419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5012008

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S12879-015-1147-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26468008

http://www.w3.org/2001/XMLSchema#string

P921

P932

4606906

http://www.w3.org/2001/XMLSchema#string